Keywords
hexabody,antibody hexamer,iGg1 hexamer,immunoglobulin G,IgG,IgG1,Ab,Genmab,CD37,GEN3009,CD27,GEN1053,BNT313,igG1 subunit,hexamer,hexameric,six antibodies,antibody hexamer,hexameric antibody,therapeutic antibodies,antibody therapeutic,novel antibody therapy,immune response,enhanced immune response,antibody binding,antibody target,pathogen binding,antigen binding,Fc region mutation,Fc region,Fc mutation,monoclonal antibody,antibody,fragment antibody binding,immunoglobulin,Ig,antibodies,subclass,domain,variable region,light chain,heavy chain,antibody fragment,fragment,disulfide bond,disulfide bridge,hinge region,antibody hinge,immune system,immunology,antigen-binding site,adaptive immune system,immune,system,molecule,macromolecule,protein,popular icons,editable,complement system,immune system,immunogenicity,immunotherapy,targeted therapy,antibody technology,protein engineering,pharmaceutical,pharmacokinetics,drug development,cancer therapy,cancer treatment,tumor treatment,tumour treatment,anti-tumour,cytotoxic,biotherapeutics,biotechnology,biotech,bioengineering,Genmab A/S,BankInvest Biomedical,sausage and link,2d,schematic,simple,two dimensional,hexabody,hexamer